Guselkumab, Risankizumab Boast Longest Drug Survival Among IL-17, IL-23 Inhibitors
A recent meta-analysis of more than 60 studies suggests guselkumab and risankizumab had the longest drug survival of IL-17 and IL-23 inhibitors for psoriasis.
A recent meta-analysis of more than 60 studies suggests guselkumab and risankizumab had the longest drug survival of IL-17 and IL-23 inhibitors for psoriasis.
Standardized and collaborative care improves liver transplantations
This study evaluated the topics, accuracy, and credibility of X (formerly Twitter) Community Notes addressing COVID-19 vaccination.
This study evaluated the topics, accuracy, and credibility of X (formerly Twitter) Community Notes addressing COVID-19 vaccination.
A 2023 Cochrane review of randomized clinical trials (RCTs) of “physical interventions to…reduce the spread of respiratory viruses”1 generated controversy and confusion in concluding that…
Payment attribution, benchmarking and risk adjustment are among essentials to consider. Learn more with a playbook developed by the AMA and others.
Wang et al. examine the challenges posed by laws in the United States and China for generative-AI-assisted genomics research collaboration. They recommend renewing the Agreement on…
The inspirational story of the compassionate animals of The Gentle Barn and how they became a therapeutic salve for many guests—and mentors for how to…
Millions of incarcerated individuals, like Kwaneta Harris, are denied vital health information due to censorship, highlighting the urgent need for medical professionals to advocate against…
“Regard for power implies disregard for those without power…”
As actors, musicians, and other creatives raise the alarm about generative AI, recent stage performances explore where this could be heading.